查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1738666

全球治疗性疫苗市场规模（依目标疾病、作用方式、给药机制、地区、范围及预测）

Global Therapeutic Vaccines Market Size By Type of Disease Targeted, By Mode of Action, By Delivery Mechanism, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

治疗性疫苗市场规模及预测

2024 年治疗性疫苗市场规模价值为 473.3 亿美元，预计到 2032 年将达到 1,782.6 亿美元，2026 年至 2032 年的复合年增长率为 18.03%。

推动全球治疗性疫苗市场的因素

  • 慢性病盛行率不断上升：随着癌症、爱滋病毒/爱滋病和自体免疫疾病等慢性病在全球的盛行率不断上升，治疗性疫苗市场的需求受到慢性病盛行率不断上升、免疫疗法市场发展、政府措施和资金以及技术创新的推动。

作为一种可能的治疗选择，它正变得越来越重要。

  • 免疫疗法发展：近年来，免疫疗法领域取得了重大突破，包括治疗性疫苗。随着新型疫苗平台的建立以及对免疫反应认知的不断加深，治疗性疫苗市场正在不断扩大。
  • 政府措施与资金：世界各国政府和监管机构正在投入越来越多的资源用于治疗性疫苗的研发。资金支持、政府核准以及疫苗研发奖励推动市场的发展。
  • 技术创新：佐剂技术、疫苗设计方法和疫苗传递系统的进步，促进了更有效、更精准的治疗性疫苗的研发。这些进步提高了治疗性疫苗的安全性和临床疗效，推动了市场的发展。
  • 个人化医疗日益受到关注：治疗性疫苗能够根据每位患者独特的免疫学和遗传特征制定个人化治疗方案。个人化医疗趋势推动了治疗性疫苗在精准医疗中的应用。
  • 製药公司加大研发支出：为了满足尚未满足的医疗需求并实现产品线多样化，製药公司正在大力投资治疗性疫苗的研发。生物製药领域的策略联盟、伙伴关係和收购正在进一步推动市场扩张。
  • 加强患者教育和认知：推动市场发展的动力源于患者和医疗保健专业人员对治疗性疫苗在治疗慢性疾病方面的益处的认识不断提高。宣传工作和病患教育计画将有助于更广泛地接受和使用治疗性疫苗。
  • 全球健康威胁与流行病：新兴感染疾病和全球健康风险，例如COVID-19疫情，凸显了疫苗研究和疫苗宣传活动的重要性。治疗性疫苗开发的投资源自于尽快对抗感染疾病的需求。

限制全球治疗性疫苗市场的因素

  • 监管挑战：治疗性疫苗的核准需要遵守严格的法规，这可能会延迟新治疗方法的推出。
  • 发现成本高：由于疫苗製造的复杂性和需要进行临床试验，治疗性疫苗的研发通常非常昂贵，这可能会限制愿意在该领域投资的公司数量。
  • 有效性有限：某些治疗性疫苗对某些患者群体或疾病的有效性可能有限，这可能会限制其可接受性和适销性。
  • 製造复杂性：生产治疗性疫苗通常涉及复杂的步骤，这会对成本效益、扩充性和一致性带来挑战。
  • 患者接受度和依从性：让患者接受并坚持治疗性疫苗接种可能具有挑战性，尤其是在需要频繁接种疫苗或有严重副作用的情况下。
  • 与其他治疗方法的衝突：传统药物疗法和其他生物製药可能提供治疗疾病的其他方法，并可能对治疗性疫苗接种构成威胁。
  • 知识和教育有限：患者和医疗保健专业人员对治疗性疫苗及其益处的无知可能会阻碍治疗性疫苗企业的发展。
  • 医疗保健基础设施挑战：由于缺乏医疗保健资源和基础设施，治疗性疫苗的分发和管理在某些地区可能会面临挑战。
  • 覆盖范围和报销问题：覆盖范围和报销不足可能会阻碍患者获得和使用治疗性疫苗，特别是在以私人医疗保健系统为主的地区。

目录

第一章 引言

  • 市场定义
  • 市场区隔
  • 调查方法

第二章执行摘要

  • 主要发现
  • 市场概览
  • 市集亮点

第三章市场概述

  • 市场规模和成长潜力
  • 市场趋势
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析

第四章 治疗性疫苗市场（依目标疾病）

  • 感染疾病
  • 癌症
  • 自体免疫疾病

5. 治疗性疫苗市场（依作用机转）

  • 免疫调变器
  • 抗原特异性疫苗
  • 细胞疫苗

6. 治疗性疫苗市场（依递送机制）

  • 常规疫苗
  • 奈米颗粒疫苗
  • 基因疫苗

第七章区域分析

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国

第八章市场动态

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • COVID-19 市场影响

第九章 竞争态势

  • 主要企业
  • 市场占有率分析

第十章 公司简介

  • Merck & Co.
  • GlaxoSmithKline
  • Pfizer
  • Moderna
  • BioNTech
  • Inovio Pharmaceuticals

第十一章 市场展望与机会

  • 新兴技术
  • 未来市场趋势
  • 投资机会

第十二章 附录

  • 简称列表
  • 来源和参考文献
简介目录
Product Code: 35680

Therapeutic Vaccines Market Size And Forecast

Therapeutic Vaccines Market size was valued at USD 47.33 Billion in 2024 and is projected to reach USD 178.26 Billion by 2032, growing at a CAGR of 18.03% during the forecast period 2026-2032.

Global Therapeutic Vaccines Market Drivers

The market drivers for the Therapeutic Vaccines Market can be influenced by various factors. These may include:

  • Increasing Prevalence of Chronic Diseases: With the prevalence of chronic illnesses including cancer, HIV/AIDS, and autoimmune disorders rising worldwide, therapeutic vaccinations aThe need for Therapeutic Vaccines Market is driven by Increasing Prevalence of Chronic Diseases, Developments in Immunotherapy, Government Initiatives and Funding and Technological Innovations

re becoming more and more important as a possible therapy option.

  • Developments in Immunotherapy: In recent years, there have been notable breakthroughs in the field of immunotherapy, which includes therapeutic vaccinations. The market for therapeutic vaccines is growing as a result of the creation of new vaccine platforms and enhanced knowledge of immune responses.
  • Government Initiatives and Funding: Around the world, governments and regulatory agencies are spending more money on the development of therapeutic vaccines. Market expansion is facilitated by financial assistance, government approvals, and incentives for vaccine development.
  • Technological Innovations: The creation of more effective and focused therapeutic vaccines has been made possible by developments in adjuvant technology, vaccine design approaches, and vaccine delivery systems. By improving the safety and clinical efficacy of therapeutic vaccines, these developments propel the market's growth.
  • Increasing Interest in Personalised Medicine: Therapeutic vaccinations present the possibility of individualised treatment plans that are based on the unique immunological and genetic profiles of each patient. The use of therapeutic vaccinations in precision medicine methods is driven by the trend towards personalised medicine.
  • Growing Pharmaceutical Companies' R&D Expenditures: Due to their potential to fill unmet medical needs and diversify product lines, pharmaceutical companies are making significant investments in the research and development of therapeutic vaccines. In the biopharmaceutical sector, strategic alliances, partnerships, and acquisitions propel market expansion even further.
  • Growing Patient Education and Awareness: The market is driven by patients' and healthcare professionals' increasing knowledge of the advantages of therapeutic vaccinations in the treatment of chronic illnesses. Advocacy and patient education programmes can make therapeutic vaccinations more widely accepted and used.
  • Global Health Threats and Pandemics: Emerging infectious illnesses and global health risks, like the COVID-19 pandemic, underscore the significance of vaccine research and vaccination campaigns. Investments in the development of therapeutic vaccines are motivated by the need to combat infectious diseases as soon as possible.

Global Therapeutic Vaccines Market Restraints

Several factors can act as restraints or challenges for the Therapeutic Vaccines Market. These may include:

  • Regulatory Difficulties: The approval of therapeutic vaccines must comply with strict regulations, which might cause delays in the launch of new treatments.
  • substantial creation expenses: Due to the complexity of vaccine creation and the requirement for clinical trials, research and development expenses for therapeutic vaccines are frequently substantial. This can restrict the number of companies who are prepared to invest in this field.
  • Limited Efficacy: The acceptance and market potential of some therapeutic vaccines may be constrained by their possible limited efficacy in specific patient populations or diseases.
  • Manufacturing Complexities: The production of therapeutic vaccines frequently involves intricate procedures, which might pose problems with cost-effectiveness, scalability, and consistency.
  • Patient Acceptance and Compliance: It can be difficult to get patients to accept and comply with therapeutic vaccinations, especially if they need to receive the shots frequently or have serious side effects.
  • Competition from Other Therapies: Traditional medications and other biologics, which may provide other methods to illness care, could pose a threat to therapeutic vaccinations.
  • Limited Knowledge and Education: The development of the therapeutic vaccine business may be hampered by patients' and healthcare professionals' ignorance of therapeutic vaccinations and their possible advantages.
  • Healthcare Infrastructure Difficulties: The distribution and administration of therapeutic vaccines may face difficulties in certain areas due to a lack of resources and infrastructure for healthcare.
  • Insurance Coverage and Reimbursement Issues: Patients' access to and use of therapeutic vaccinations may be hampered by inadequate insurance coverage and reimbursement, especially in areas with predominately private healthcare systems.

Global Therapeutic Vaccines Market Segmentation Analysis

The Global Therapeutic Vaccines Market is Segmented on the basis of Type of Disease Targeted, Mode of Action, Delivery Mechanism, and Geography.

Therapeutic Vaccines Market, By Type of Disease Targeted

  • Infectious Diseases: These vaccines target infectious diseases caused by viruses, bacteria, or other pathogens.
  • Cancer: Therapeutic vaccines for cancer aim to stimulate the immune system to recognize and destroy cancer cells.
  • Autoimmune Diseases: Vaccines designed to modulate the immune response in autoimmune conditions like rheumatoid arthritis or multiple sclerosis.

Therapeutic Vaccines Market, By Mode of Action

  • Immune Modulators: These vaccines work by modulating the immune system, either by activating or suppressing certain immune responses.
  • Antigen-Specific Vaccines: Targeting specific antigens associated with a disease, these vaccines train the immune system to recognize and attack the pathogen or diseased cells.
  • Cell-Based Vaccines: Utilizing cells, such as dendritic cells, to present antigens to the immune system and trigger an immune response.

Therapeutic Vaccines Market, By Delivery Mechanism

  • Traditional Vaccines: Administered via injection, similar to traditional vaccines for prevention.
  • Nanoparticle-Based Vaccines: Utilizing nanoparticles as carriers for vaccine antigens, enhancing delivery and immune response.
  • Gene-Based Vaccines: Employing genetic material, such as DNA or RNA, to encode antigens and stimulate an immune response.

Therapeutic Vaccines Market, By Geography

  • North America: Market conditions and demand in the United States, Canada, and Mexico.
  • Europe: Analysis of the Therapeutic Vaccines Market in European countries.
  • Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
  • Middle East and Africa: Examining market dynamics in the Middle East and African regions.
  • Latin America: Covering market trends and developments in countries across Latin America.

Key Players

  • The major players in the Therapeutic Vaccines Market are:
  • Merck & Co.
  • GlaxoSmithKline
  • Pfizer
  • Moderna
  • BioNTech
  • Inovio Pharmaceuticals
  • Bavarian Nordic
  • Argos Therapeutics
  • Antigenics
  • Affiris
  • Celldex Therapeutics
  • Biovest International
  • Cel-Sci
  • Celtic Pharma
  • Cytos Biotechnology
  • Curevac

TABLE OF CONTENTS

1. Introduction

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Therapeutic Vaccines Market, By Type of Disease Targeted

  • Infectious Diseases
  • Cancer
  • Autoimmune Diseases

5. Therapeutic Vaccines Market, By Mode of Action

  • Immune Modulators
  • Antigen-Specific Vaccines
  • Cell-Based Vaccines

6. Therapeutic Vaccines Market, By Delivery Mechanism

  • Traditional Vaccines
  • Nanoparticle-Based Vaccines
  • Gene-Based Vaccines

7. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

8. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

9. Competitive Landscape

  • Key Players
  • Market Share Analysis

10. Company Profiles

  • Merck & Co.
  • GlaxoSmithKline
  • Pfizer
  • Moderna
  • BioNTech
  • Inovio Pharmaceuticals

11. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

12. Appendix

  • List of Abbreviations
  • Sources and References